HIMS), the maker of prescription compound drugs that has amassed a popular following from its personalized pill prescriptions ...

Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisk's diabetes drug, liraglutide, to its platform in 2025.

If you’re prescribed Viagra, Hims will mail it directly to you in individual single-use pill packets. Viagra is intended to be taken as needed before sexual activity and can reduce ED symptoms ...

There are safer alternatives to male enhancement pills, like doctor-prescribed ED medications and wearable devices. Hims offers several ED medications, including pills for one-time use and those ...

Hims & Hers Health Inc. said an analysis of more than 10,000 patients taking a copycat version of Novo Nordisk A/S’s Ozempic and Wegovy showed the shot was a safe and effective way to shed pounds.

Allen Lutz, an analyst from Bank of America Securities, maintained the Buy rating on Hims & Hers Health (HIMS – Research Report). The associated price target remains the same with $25.00.

Hims & Hers Health will join the S&P SmallCap 600 prior to the opening of trading on Wednesday. Hims & Hers will replace Vector Group, which is being acquired by JT Group. Hims & Hers Health Inc ...

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our P/B Growth Investor model based on the published ...

Hims & Hers Health (HIMS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Cherny from Leerink Partners reiterated a Hold rating on ...